D3 Bio
San Diego, United States· Est.
D3 Bio develops innovative biologic and small molecule drugs for oncology and immunology with a focus on targeted therapies.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $108M
About
D3 Bio develops innovative biologic and small molecule drugs for oncology and immunology with a focus on targeted therapies.
OncologyImmunologyBiologics
Funding History
1Total raised:$108M
Venture$108M